|
|
Global Analysis
Results: 1-10 out of 137 |
Next 10 »
- After several quarters of flagging sales, big makers of spinal devices have started reporting a new source of pressure on the $7.1 billion market: insurance companies.
By Jon Kamp Of DOW JONES NEWSWIRES . August 31, 2010
- FDA seeks to address industry concerns about device-approval process
By Shawn Rhea, Modern Healthcare. August 31, 2010
- U.S. Judge Rules Against Obama’s Stem Cell Policy
By GARDINER HARRIS, New York Times. August 23, 2010
- Pushing Back on Back Surgery
by Aviva Mishmari . August 22, 2010
- Is It Time We Paid More Attention to Rare Diseases?
by Aviva Mishmari . August 22, 2010
- FDA challenges stem-cell clinic
by Aviva Mishmari . August 20, 2010
- FDA faces outcry with Avastin choice – An interesting Dilema for FDA and Industry
By Tracy Staton, FiercePharma. August 17, 2010
- Health Care Reform Implementation Moves Forward Despite Continued Opposition
By Kevin Kappel, Tom Koutsoumpas, and Jeremy Rabinovitz- Mintz Levine. August 17, 2010
- 1 in 5 Hospitalizations Involve Diabetes Patients
Cheryl Clark, for HealthLeaders Media. August 16, 2010
- Medicare Reimbursement Changes May Lead to More Antibiotic Use
Janice Simmons, for HealthLeaders Media. August 16, 2010
Results: 1-10 out of 137 |
Next 10 »
|
|